Status:
UNKNOWN
The BIOPRES Trial: Transrectal BIOpsies of the PRostate: End Versus Side-firing
Lead Sponsor:
Amphia Hospital
Conditions:
Prostate Cancer
Eligibility:
MALE
Phase:
PHASE3
Brief Summary
The purpose of this study is to study the difference in prostate cancer between two prostate biopsy techniques, namely end-firing and side-firing. These differ in the angle at which the prostate is bi...
Detailed Description
Rationale: Research towards the efficacy of transrectal prostate biopsies has predominantly focused on the amount of biopsy cores. However, variation in the angle of entrance of the biopsy gun has bee...
Eligibility Criteria
Inclusion
- PSA and DRE performed in advance of the biopsy
- Informed consent
- Number of biopsy cores according to the volume dependent biopsy protocol (8 cores in prostates with a volume less than 40 mL., 10 in 40-60 mL. and 12 in \>60 mL.)
Exclusion
- None
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2012
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT00851292
Start Date
October 1 2009
End Date
September 1 2012
Last Update
June 22 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Amphia hospital
Breda, North Brabant, Netherlands